What question did this study set out to answer?

This study aimed to develop and validate a rapid assay for the detection of Group B Streptococcus (GBS) in pregnant women.

Validation of an in-house developed rapid assay for Group B Streptococcus detection in pregnancy

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial evaluates rapid GBS detection in pregnant women, suggesting improved clinical outcomes.

This study aimed to develop and validate a rapid assay for the detection of Group B Streptococcus (GBS) in pregnant women.
Established a rapid detection platform using CRISPR/Cas12a and recombinase polymerase amplification (RPA).
Evaluated diagnostic performance against commercial quantitative real-time PCR (qPCR) with 1,000 clinical swabs.
Conducted specificity assessments against other common pathogens.
The rapid assay achieved a detection limit of 201.64 copies/µl (95% CI: 66.90–607.75).
Results correlated closely with the conventional qPCR method, indicating high sensitivity and specificity.
Test results were available within one hour, offering significant time advantages over traditional methods.

Hu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark